Table 3 Anticipated child self-report visual analogue scale, willingness to pay and time trade off for each of the hypothetical four different febrile neutropaenia management strategies (N=43)

	Value	β ±s.e.	P- value
Median VAS score (IQR)			0.488^a
Inpatient	5.7 (4.1, 7.9)	REF	REF
Early discharge	6.1 (4.6, 7.2)	0.20±0.26	0.438
Outpatient i.v.	5.6 (4.6, 7.0)	−0.07±0.38	0.845
Outpatient PO	5.3 (4.3, 7.3)	−0.30±0.53	0.569
Median WTP score (IQR) ^b			0.004^a
Inpatient	0	REF	REF
Early discharge	50.0 (0.0, 150.0)	241.3±98.3	0.016
Outpatient i.v.	62.5 (0.0, 250.0)	218.3±68.4	0.0008
Outpatient PO	45.0 (0.0, 185.0)	197.8±70.8	0.006
Median TTO presented as weeks given up (IQR)			0.049^a
Inpatient	0	REF	REF
Early discharge	7.3 (0.0, 156.0)	20.9±11.4	0.069
Outpatient i.v.	10.9 (0.0, 156.0)	11.3±6.3	0.076
Outpatient PO	7.3 (0.0, 104.0)	7.4±2.8	0.010

Abbreviations: IQR=interquartile range; i.v.=intravenous; PO=outpatient oral; REF=reference; TTO=time trade-off technique; VAS=visual analogue scale; WTP=willingness-to-pay.
^aThese P-values represent differences across the four groups using repeated measures analysis.
^bIn Canadian dollars.

Quick links

Search